Tag: Savara Pharmaceuticals

Keiretsu Forum Invests $3 Million in Savara Pharmaceuticals

The Keiretsu Forum’s members gave $3 million as the lead investor on a Series B round for Savara Pharmaceuticals.
Savara is developing pulmonary drugs to treat serious and life threatening conditions.
“The opportunity to invest in Savara Pharmaceuticals attracted many of our accredited investors, who are deeply committed to supporting products and technologies with the potential to positively impact people’s lives,” Randy Williams, Founder and CEO of Keiretsu Forum, said in a news release. “With a solid business plan for developing an innovative and much-needed product, Savara exemplifies the type of company Keiretsu Forum members are seeking to identify and support. We are proud to have given Savara a giant leap forward and look forward to working with our members and entrepreneurs in funding other exciting enterprises.”
So far, Savara has raised more than $8 million in its latest financing round. The company plans to use the money on its lead product, AeroVanc, an antibiotic inhalant to treat MRSA infection, which is a Phase II clinical trial.
“The Keiretsu Forum takes a disciplined approach to deal screening, in-depth due diligence and investing, enabling companies to access a large group of sophisticated investors and enabling its members to access pre-qualified deal flow,” Robert Neville, Chief Executive Officer of Savara Pharmaceuticals, said in a statement. “The enthusiasm Savara received has been tremendous, and we are delighted for the Keiretsu Forum’s member support as we work to advance our lead program through Phase II clinical development.”

ATI graduates 21 companies tonight

The Austin Technology Incubator, a non-profit organization affiliated with the IC2 Institute of the University of Texas, will host a graduation ceremony tonight for 21 of its member companies.
The event also celebrates the 23 years ATI has helped incubate central Texas companies. Founded by Dr. George Kozmetsky and first directed by Laura Kilcrease, ATI has worked with more than 200 status companies and helped them raise more than $1 billion in capital, according to this news release. Silicon Hills News will be there tonight to cover the event. So stay tuned for more information.

© 2024 SiliconHills

Theme by Anders NorenUp ↑